Literature DB >> 2212940

Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice.

M Matloubian1, T Somasundaram, S R Kolhekar, R Selvakumar, R Ahmed.   

Abstract

This study has identified a single amino acid change in the viral glycoprotein that profoundly affects the ability of lymphocytic choriomeningitis virus (LCMV) to persist in its natural host. Adult immunocompetent mice infected with a variant of the Armstrong strain, spleen isolate clone 13 (svA/svA), harbor virus for several months and exhibit suppressed T cell responses. In contrast, adult mice infected with a reassortant virus (svA/wtA) that contains the L segment of the spleen variant and the S segment of the parental wt Armstrong, make potent LCMV-specific CTL responses and clear the infection within 2-4 wk. These two viruses, spleen variant clone 13 and the reassortant svA/wtA, are identical in their noncoding regions and show no amino acid changes in any of their viral genes except for one substitution in the glycoprotein. The reassortant virus svA/wtA has a phenylalanine at amino acid residue 260 of the glycoprotein, whereas the spleen variant clone 13 has a leucine at this position. This study constitutes one of the first reports defining the genetic basis of viral persistence at the whole animal level, and identifying a single mutation that markedly increases the ability of a virus to persist in its natural host.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212940      PMCID: PMC2188602          DOI: 10.1084/jem.172.4.1043

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis.

Authors:  Y Riviere; M B Oldstone
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 2.  Ambisense RNA genomes of arenaviruses and phleboviruses.

Authors:  D H Bishop
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

3.  Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells.

Authors:  B D Jamieson; L D Butler; R Ahmed
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response.

Authors:  D Moskophidis; S P Cobbold; H Waldmann; F Lehmann-Grube
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins.

Authors:  M J Buchmeier; P J Southern; B S Parekh; M K Wooddell; M B Oldstone
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus.

Authors:  P J Southern; M K Singh; Y Riviere; D R Jacoby; M J Buchmeier; M B Oldstone
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

7.  H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.

Authors:  R M Zinkernagel; R M Welsh
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

8.  Immune therapy of a persistent and disseminated viral infection.

Authors:  R Ahmed; B D Jamieson; D D Porter
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

9.  Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-).

Authors:  M Salvato; E Shimomaye; P Southern; M B Oldstone
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

10.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.

Authors:  R Ahmed; A Salmi; L D Butler; J M Chiller; M B Oldstone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  67 in total

1.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells.

Authors:  S M Kaech; R Ahmed
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

2.  Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity.

Authors:  A M Doling; J D Ballard; H Shen; K M Krishna; R Ahmed; R J Collier; M N Starnbach
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  Viral persistence in vivo through selection of neutralizing antibody-escape variants.

Authors:  A Ciurea; P Klenerman; L Hunziker; E Horvath; B M Senn; A F Ochsenbein; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution.

Authors:  Lalit K Beura; Kristin G Anderson; Jason M Schenkel; Jeremiah J Locquiao; Kathryn A Fraser; Vaiva Vezys; Marion Pepper; David Masopust
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

5.  Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Authors:  Brian M Sullivan; Sébastien F Emonet; Megan J Welch; Andrew M Lee; Kevin P Campbell; Juan C de la Torre; Michael B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

6.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

7.  Molecular basis of organ-specific selection of viral variants during chronic infection.

Authors:  R Ahmed; C S Hahn; T Somasundaram; L Villarete; M Matloubian; J H Strauss
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.

Authors:  Tobias A W Holderried; Philipp A Lang; Hye-Jung Kim; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

9.  Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.

Authors:  Scott N Mueller; Mehrdad Matloubian; Daniel M Clemens; Arlene H Sharpe; Gordon J Freeman; Shivaprakash Gangappa; Christian P Larsen; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

10.  Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.

Authors:  M Salvato; P Borrow; E Shimomaye; M B Oldstone
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.